{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:17:42Z","timestamp":1765610262483,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00280-022-04460-0","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T08:02:45Z","timestamp":1660377765000},"page":"279-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia"],"prefix":"10.1007","volume":"90","author":[{"given":"Honami","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-7517","authenticated-orcid":false,"given":"Takahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanako","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kitadate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"6","key":"4460_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.4149\/neo_2013_085","volume":"60","author":"SV Mehta","year":"2013","unstructured":"Mehta SV, Shukla SN, Vora HH (2013) Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3. Neoplasma 60(6):666\u2013675","journal-title":"Neoplasma"},{"issue":"9","key":"4460_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2019.00192","volume":"27","author":"A McBride","year":"2019","unstructured":"McBride A, Houtmann S, Wilde L, Vigil C, Eischen CM, Kasner M et al (2019) The role of inhibition of apoptosis in acute leukemias and myelodysplastic syndrome. Front Oncol 27(9):192. https:\/\/doi.org\/10.3389\/fonc.2019.00192","journal-title":"Front Oncol"},{"issue":"13","key":"4460_CR3","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1158\/1078-0432.CCR-19-1900","volume":"26","author":"S Jin","year":"2020","unstructured":"Jin S, Cojocari D, Purkal JJ, Popovic R, Talaty NN, Xiao Y et al (2020) 5-Azacitidine induces NOXA to prime AML cells for venetoclax-mediated apoptosis. Clin Cancer Res 26(13):3371\u20133383. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1900","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4460_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH et al (2020) Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383(7):617\u2013629","journal-title":"N Engl J Med"},{"issue":"4","key":"4460_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/QAI.0b013e318232b057","volume":"58","author":"BM Best","year":"2011","unstructured":"Best BM, Capparelli EV, Diep H, Rossi SS, Farrell MJ, Williams E et al (2011) Pharmacokinetics of lopinavir\/ritonavir crushed versus whole tablets in children. J Acquir Immune Defic Syndr 58(4):385\u2013391","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4460_CR6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s10637-011-9725-2","volume":"30","author":"EI Heath","year":"2012","unstructured":"Heath EI, Forman K, Malburg L, Gainer S, Suttle AB, Adams L et al (2012) A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. Investig New Drugs 30(4):1566\u20131574. https:\/\/doi.org\/10.1007\/s10637-011-9725-2","journal-title":"Investig New Drugs"},{"issue":"4","key":"4460_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/FTD.0000000000000203","volume":"37","author":"M Britzi","year":"2015","unstructured":"Britzi M, Berkovitch M, Soback S, Leibovitz A, Segal R, Smagarinsky M et al (2015) Roxithromycin pharmacokinetics in hospitalized geriatric patients: oral administration of whole versus crushed tablets. Ther Drug Monit 37(4):512\u2013515","journal-title":"Ther Drug Monit"},{"issue":"11","key":"4460_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/phar.1835","volume":"36","author":"E Huesgen","year":"2016","unstructured":"Huesgen E, DeSear KE, Egelund EF, Smith R, Max B, Janelle J (2016) A HAART-breaking review of alternative antiretroviral administration: practical considerations with crushing and enteral tube scenarios. Pharmacotherapy 36(11):1145\u20131165. https:\/\/doi.org\/10.1002\/phar.1835","journal-title":"Pharmacotherapy"},{"issue":"24","key":"4460_CR9","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","volume":"21","author":"BD Cheson","year":"2003","unstructured":"Cheson BD, Bennett JM, Kopecky KJ, B\u00fcchner T, Willman CL, Estey EH et al (2003) Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21(24):4642\u20134649","journal-title":"J Clin Oncol"},{"issue":"6","key":"4460_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jjco\/hyab018","volume":"51","author":"S Taniguchi","year":"2021","unstructured":"Taniguchi S, Yamauchi T, Choi I, Fukuhara N, Potluri J, Salem AH et al (2021) Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings. Jpn J Clin Oncol 51(6):857\u2013864. https:\/\/doi.org\/10.1093\/jjco\/hyab018","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"4460_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.xphs.2017.09.027","volume":"107","author":"A EmamiRiedmaier","year":"2018","unstructured":"EmamiRiedmaier A, Lindley DJ, Hall JA, Castleberry S, Slade RT, Stuart P et al (2018) Mechanistic physiologically based pharmacokinetic modeling of the dissolution and food effect of a biopharmaceutics classification system IV compound-the venetoclax story. J Pharm Sci 107(1):495\u2013502. https:\/\/doi.org\/10.1016\/j.xphs.2017.09.027","journal-title":"J Pharm Sci"},{"issue":"2","key":"4460_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clinthera.2017.01.003","volume":"39","author":"SK Agarwal","year":"2017","unstructured":"Agarwal SK, DiNardo CD, Potluri J, Dunbar M, Kantarjian HM, Humerickhouse RA et al (2017) Management of venetoclax-posaconazole interaction in acute myeloid leukemia patients: evaluation of dose adjustments. Clin Ther 39(2):359\u2013367. https:\/\/doi.org\/10.1016\/j.clinthera.2017.01.003","journal-title":"Clin Ther"},{"issue":"11","key":"4460_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/jcph.730","volume":"56","author":"SK Agarwal","year":"2016","unstructured":"Agarwal SK, Hu B, Chien D, Wong SL, Salem AH (2016) Evaluation of rifampin\u2019s transporter inhibitory and CYP3A inductive effects on the pharmacokinetics of venetoclax, a BCL-2 inhibitor: results of a single- and multiple-dose study. J Clin Pharmacol 56(11):1335\u20131343. https:\/\/doi.org\/10.1002\/jcph.730","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"4460_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/pharmaceutics14040694","volume":"14","author":"ED Eisenmann","year":"2022","unstructured":"Eisenmann ED, Garrison DA, Talebi Z, Jin Y, Silvaroli JA, Kim JG et al (2022) Interaction of antifungal drugs with CYP3A- and OATP1B-mediated venetoclax elimination. Pharmaceutics 14(4):694. https:\/\/doi.org\/10.3390\/pharmaceutics14040694","journal-title":"Pharmaceutics"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-022-04460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-022-04460-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-022-04460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:04:01Z","timestamp":1661353441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-022-04460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s00280-022-04460-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted with written informed consent of the patient and approval by the ethics committee of Akita University Graduate School of Medicine (no. 2696).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and ethical approval"}}]}}